At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BHST BIOHARVEST SCIENCES INC
Pre-Mkt 12-16 05:44:43 EST
5.20
-0.10
-1.89%
High5.38Low5.10Vol49.28K
Open5.34D1 Closing5.30Amplitude5.28%
Mkt Cap117.80MTradable Cap92.64MTotal Shares22.65M
T/O256.17KT/O Rate0.28%Tradable Shares17.82M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Analysts Offer Insights on Consumer Goods Companies: BioHarvest Sciences (BHST) and JM Smucker (SJM)
TIPRANKS  ·  11-26
Analysts Offer Insights on Consumer Goods Companies: BioHarvest Sciences (BHST) and JM Smucker (SJM)
BioHarvest Sciences Inc. - Common Stock Q3 EPS $(0.14) Misses $(0.12) Estimate, Sales $9.067M Miss $9.123M Estimate
Benzinga  ·  11-14
BioHarvest Sciences Inc. - Common Stock Q3 EPS $(0.14) Misses $(0.12) Estimate, Sales $9.067M Miss $9.123M Estimate
BioHarvest Sciences Inc. reports Q3 revenue of $9.1 million
Reuters  ·  11-14
BioHarvest Sciences Inc. reports Q3 revenue of $9.1 million
BioHarvest Sciences Inc. to Attend Craig-Hallum Alpha Select Conference
Reuters  ·  11-12
BioHarvest Sciences Inc. to Attend Craig-Hallum Alpha Select Conference
Analysts Offer Insights on Consumer Goods Companies: BioHarvest Sciences (BHST) and HF Foods Group (HFFG)
TIPRANKS  ·  11-12
Analysts Offer Insights on Consumer Goods Companies: BioHarvest Sciences (BHST) and HF Foods Group (HFFG)
Bioharvest Sciences Inc. to Release Third Quarter 2025 Results
Reuters  ·  11-04
Bioharvest Sciences Inc. to Release Third Quarter 2025 Results
BioHarvest Sciences and Saffron Tech Partner to Develop Saffron-Derived Compounds
Reuters  ·  11-01
BioHarvest Sciences and Saffron Tech Partner to Develop Saffron-Derived Compounds
BioHarvest Sciences Guides Q4 2025 Revenue at $9–$9.5 Million with Adjusted EBITDA Near Breakeven
Reuters  ·  11-01
BioHarvest Sciences Guides Q4 2025 Revenue at $9–$9.5 Million with Adjusted EBITDA Near Breakeven
BioHarvest Sciences (BHST) Gets a Buy from Craig-Hallum
TIPRANKS  ·  10-30
BioHarvest Sciences (BHST) Gets a Buy from Craig-Hallum
Bioharvest Sciences Inc. Reduces Debt by $3.8 Million and Secures $10.9 Million in Cash Proceeds to Strengthen Balance Sheet
Reuters  ·  09-22
Bioharvest Sciences Inc. Reduces Debt by $3.8 Million and Secures $10.9 Million in Cash Proceeds to Strengthen Balance Sheet
BioHarvest Sciences Unveils Pre-Close Briefing on Financial Results Ahead of September 10, 2025 Investor Webinar
Reuters  ·  09-11
BioHarvest Sciences Unveils Pre-Close Briefing on Financial Results Ahead of September 10, 2025 Investor Webinar
Bioharvest Sciences Inc. Expands Capabilities with Breakthrough in Plant-Based Exosome Production at Scale
Reuters  ·  09-10
Bioharvest Sciences Inc. Expands Capabilities with Breakthrough in Plant-Based Exosome Production at Scale
Bioharvest Sciences Inc. Files Shelf Registration Statement to Potentially Offer Up to $100 Million in Securities
Reuters  ·  09-09
Bioharvest Sciences Inc. Files Shelf Registration Statement to Potentially Offer Up to $100 Million in Securities
BRIEF-Bioharvest Sciences Files For Mixed Shelf Of Up To $100 Mln
Reuters  ·  08-28
BRIEF-Bioharvest Sciences Files For Mixed Shelf Of Up To $100 Mln
Bioharvest Sciences Inc Files for Mixed Shelf of up to $100 Mln - SEC Filing
THOMSON REUTERS  ·  08-28
Bioharvest Sciences Inc Files for Mixed Shelf of up to $100 Mln - SEC Filing
Bioharvest Sciences Inc reports results for the quarter ended June 30 - Earnings Summary
Reuters  ·  08-13
Bioharvest Sciences Inc reports results for the quarter ended June 30 - Earnings Summary
BioHarvest Sciences Inc. - Common Stock Q2 EPS $(0.24) Misses $(0.06) Estimate, Sales $8.515M Miss $13.785M Estimate
Benzinga  ·  08-11
BioHarvest Sciences Inc. - Common Stock Q2 EPS $(0.24) Misses $(0.06) Estimate, Sales $8.515M Miss $13.785M Estimate
Calendar of U.S. Earnings Expected in the Week Ahead
Dow Jones  ·  08-11
Calendar of U.S. Earnings Expected in the Week Ahead
Bioharvest Sciences Inc expected to post a loss of 11 cents a share - Earnings Preview
Reuters  ·  08-08
Bioharvest Sciences Inc expected to post a loss of 11 cents a share - Earnings Preview
BioHarvest Sciences Inc. Releases Pre-Close Brief Ahead of August 11, 2025, Earnings Call to Discuss Q2 Financial Results
Reuters  ·  08-06
BioHarvest Sciences Inc. Releases Pre-Close Brief Ahead of August 11, 2025, Earnings Call to Discuss Q2 Financial Results

Introduction

Company Name.
BIOHARVEST SCIENCES INC
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. It engages in research and development of science based therapeutic solutions for the nutraceutical industry; and plant cell-based active pharmaceutical ingredients that can assist in the treatment of specific medical indications The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product; and medical cannabis. BioHarvest Sciences Inc. is based in Vancouver, Canada.
Issue price:
--